Form 4: Lemaitre Vascular Inc. Executive Acquires Shares Through Dividend Equivalent Rights

Lemaitre Vascular Inc.'s President and Director, David B. Roberts, acquired shares through the release of dividend equivalent rights, as part of a restricted stock unit vesting.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc., acquired shares of common stock on December 9, 2024.
• The shares were acquired through the release of dividend equivalent rights, which were tied to a restricted stock unit award granted on December 8, 2023.
• A total of 15,359 shares were acquired, with 169 shares sold at $101.12 per share to cover tax obligations.
• The dividend equivalent rights were released on a one-for-one basis, meaning each right was equivalent to one share of common stock.

Sentiment

Score: 7

Explanation: The transaction is a routine part of executive compensation and indicates confidence from the executive, which is generally positive.

Positives

• The acquisition of shares by a key executive can be seen as a positive sign of confidence in the company's future.

Industry Context

This type of transaction is common for executive compensation packages, where restricted stock units and dividend equivalent rights are used to align executive interests with shareholder value.

Comparison to Industry Standards

• The use of restricted stock units and dividend equivalent rights is a standard practice in executive compensation across the medical device industry.
• Many companies, such as Medtronic and Boston Scientific, use similar methods to incentivize their executives.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates executive confidence in the company.

Key Dates

Keywords

Lemaitre Vascular Inc., David B. Roberts, dividend equivalent rights, restricted stock units, share acquisition, executive compensation, insider trading